High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit.

Hassett, Michael J; McNiff, Kristen K; Dicker, Adam P; Gilligan, Timothy; Hendricks, Carolyn B; Lennes, Inga; Murray, Thomas; Krzyzanowska, Monika K

Hassett, Michael J; McNiff, Kristen K; Dicker, Adam P; Gilligan, Timothy; Hendricks, Carolyn B; Lennes, Inga; Murray, Thomas; Krzyzanowska, Monika K.

Afiliación

Hassett MJ; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
McNiff KK; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Dicker AP; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Gilligan T; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Hendricks CB; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Lennes I; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Murray T; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi
Krzyzanowska MK; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Thomas Jefferson University, Philadelphia, PA; Cleveland Clinic, Cleveland, OH; Center for Breast Health, Bethesda, MD; and Princess Margaret Hospi

J Oncol Pract ; 10(3): e160-6, 2014 May.

Article en En | MEDLINE | ID: mdl-24549319

Asunto(s)

Neoplasias/terapia; Garantía de la Calidad de Atención de Salud; Humanos; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Garantía de la Calidad de Atención de Salud / Neoplasias Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Oncol Pract Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google